Fe-containing metal-organic framework with D-penicillamine for cancer-specific hydrogen peroxide generation and enhanced chemodynamic therapy

Chemodynamic therapy (CDT) is based on the production of cytotoxic reactive oxygen species, such as hydroxyl radicals (•OH). Thus, CDT can be advantageous when it is cancer-specific, in terms of efficacy and safety. Therefore, we propose NH2-MIL-101(Fe), a Fe-containing metal-organic framework (MOF), as a carrier of Cu (copper)-chelating agent, d-penicillamine (d-pen; i.e., the NH2-MIL-101(Fe)/d-pen), as well as a catalyst with Fe-metal clusters for Fenton reaction. NH2-MIL-101(Fe)/d-pen in the form of nanoparticles was efficiently taken into cancer cells and released d-pen in a sustained manner. The released d-pen chelated Cu that is highly expressed in cancer environments and this produces extra H2O2, which is then decomposed by Fe in NH2-MIL-101(Fe) to generate •OH. Therefore, the cytotoxicity of NH2-MIL-101(Fe)/d-pen was observed in cancer cells, not in normal cells. We also suggest a formulation of NH2-MIL-101(Fe)/d-pen combined with NH2-MIL-101(Fe) loaded with the chemotherapeutic drug, irinotecan (CPT-11; NH2-MIL-101(Fe)/CPT-11). When intratumorally injected into tumor-bearing mice in vivo, this combined formulation exhibited the most prominent anticancer effects among all tested formulations, owing to the synergistic effect of CDT and chemotherapy.

Droplet-Splitting Microchip Online Coupled with Time-Resolved ICPMS for Analysis of Released Fe and Pt in Single Cells Treated with FePt Nanoparticles

The intracellular release of Fe/Pt ions from FePt nanoparticles (NPs) in single cells is highly critical to elucidate the potential cytotoxicity or potential cell protection mechanism of FePt NPs. For the first time, the quantitative analysis of Fe/Pt released from FePt-Cys NPs in single cells was achieved by a droplet-splitting microchip coupled online to inductively coupled plasma mass spectrometry detection. The droplet-splitting chip integrates droplet generation, cell lysis, and droplet-splitting units. The quantification of released Fe/Pt was achieved via measuring standard Fe/Pt ionic solutions. For the determination of total Fe/Pt in single cells, the same microchip with different operation modes (total-mode) was used, and the quantification of total Fe/Pt was achieved with FePt NPs as the standard. The developed method with two analysis modes was applied to study the decomposition behavior of FePt-Cys NPs in single cells, and the results indicated that the percentages of the cells absorbing/decomposing FePt-Cys NPs increased with the incubation time. Almost all cells absorbed FePt-Cys NPs after 6 h, while only about 60% cells decomposed FePt-Cys NPs after 6 h and almost all cells decomposed FePt-Cys NPs after 18 h. Besides, the released Fe content was lower than its endogenous content in cells and the release rate of Pt was higher than that of Fe, providing a possibility that the released Pt may contribute more to cytotoxicity. The developed system enabled fractionation of Fe/Pt in single cells treated with FePt NPs with high accuracy, easy operation, and high throughput and showed a great potential for elemental speciation at the single-cell level.

Efficient tailoring of platinum nanoparticles supported on multiwalled carbon nanotubes for cancer therapy

Aim: Therapeutically targeting cancer stem cells (CSCs), which play a role in tumor initiation and relapse, remains challenging. Materials & methods: Novel-formulated platinum nanoparticles (Pt-NPs) supported on polybenzimidazole (PBI)-functionalized polymers and multiwalled carbon nanotubes (MWCNT) were prepared and their effect on CSCs was evaluated. Results: Pt-NPs showed homogenous distribution on the surface of MWCNT/PBI composites, with very narrow particle size. MWCNT/PBI/Pt-NPs resulted in a dramatic decrease in the proliferation rate of CSCs but not bone marrow mesenchymal stem cells (BM-MSCs). Quantitative gene expression analysis revealed that MWCNT/PBI/Pt had a significant inhibitory effect on the epithelial-mesenchymal transition and cell cycle markers of CSCs. Conclusion: MWCNT/PBI/Pt exhibited a specific cytotoxic effect on breast CSCs but not on adult stem cells.

Graphene-Based Smart Platforms for Combined Cancer Therapy

The extensive research of graphene and its derivatives in biomedical applications during the past few years has witnessed its significance in the field of nanomedicine. Starting from simple drug delivery systems, the application of graphene and its derivatives has been extended to a versatile platform of multiple therapeutic modalities, including photothermal therapy, photodynamic therapy, magnetic hyperthermia therapy, and sonodynamic therapy. In addition to monotherapy, graphene-based materials are widely applied in combined therapies for enhanced anticancer activity and reduced side effects. In particular, graphene-based materials are often designed and fabricated as "smart" platforms for stimuli-responsive nanocarriers, whose therapeutic effects can be activated by the tumor microenvironment, such as acidic pH and elevated glutathione (termed as "endogenous stimuli"), or light, magnetic, or ultrasonic stimuli (termed as "exogenous stimuli"). Herein, the recent advances of smart graphene platforms for combined therapy applications are presented, starting with the principle for the design of graphene-based smart platforms in combined therapy applications. Next, recent advances of combined therapies contributed by graphene-based materials, including chemotherapy-based, photothermal-therapy-based, and ultrasound-therapy-based synergistic therapy, are outlined. In addition, current challenges and future prospects regarding this promising field are discussed.

Cancer Treatment through Nanoparticle-Facilitated Fenton Reaction

Currently, cancer is the second largest cause of death worldwide and has reached critical levels. In spite of all the efforts, common treatments including chemotherapy, photodynamic therapy, and photothermal therapy suffer from various problems which limit their efficiency and performance. For this reason, different strategies are being explored which improve the efficiency of these traditional therapeutic methods or treat the tumor cells directly. One such strategy utilizing the Fenton reaction has been investigated by many groups for the possible treatment of cancer cells. This approach is based on the knowledge that high levels of hydrogen peroxide exist within cancer cells and can be used to catalyze the Fenton reaction, leading to cancer-killing reactive oxygen species. Analysis of the current literature has shown that, due to the diverse morphologies, different sizes, various chemical properties, and the tunable structure of nanoparticles, nanotechnology offers the most promising method to facilitate the Fenton reaction with cancer therapy. This review aims to highlight the use of the Fenton reaction using different nanoparticles to improve traditional cancer therapies and the emerging Fenton-based therapy, highlighting the obstacles, challenges, and promising developments in each of these areas.

Carbon Nanomaterials in Optical Detection

Owing to their unique optical, electronic, mechanical, and chemical properties, flexible chemical modification, large surface coverage and ready cellular uptake, various carbon nanomaterials such as carbon nanotubes (CNTs), graphene and its derivatives, carbon dots (CDs), graphene quantum dots, fullerenes, carbon nanohorns (CNHs) and carbon nano-onions (CNOs), have been widely explored for use in optical detection. Most of them are based on fluorescence changes. In this chapter, we will focus on carbon nanomaterials-based optical detection applications, mainly including fluorescence sensing and bio-imaging. Moreover, perspectives on future exploration of carbon nanomaterials for optical detection are also given.

Platinum nanoparticles in nanobiomedicine

Oxidative stress-dependent inflammatory diseases represent a major concern for the population's health worldwide. Biocompatible nanomaterials with enzymatic properties could play a crucial role in the treatment of such pathologies. In this respect, platinum nanoparticles (PtNPs) are promising candidates, showing remarkable catalytic activity, able to reduce the intracellular reactive oxygen species (ROS) levels and impair the downstream pathways leading to inflammation. This review reports a critical overview of the growing evidence revealing the anti-inflammatory ability of PtNPs and their potential applications in nanomedicine. It provides a detailed description of the wide variety of synthetic methods recently developed, with particular attention to the aspects influencing biocompatibility. Special attention has been paid to the studies describing the toxicological profile of PtNPs with an attempt to draw critical conclusions. The emerging picture suggests that the material per se is not causing cytotoxicity, while other physicochemical features related to the synthesis and surface functionalization may play a crucial role in determining the observed impairment of cellular functions. The enzymatic activity of PtNPs is also summarized, analyzing their action against ROS produced by pathological conditions within the cells. In particular, we extensively discuss the potential of these properties in nanomedicine to down-regulate inflammatory pathways or to be employed as diagnostic tools with colorimetric readout. A brief overview of other biomedical applications of nanoplatinum is also presented.

Multifunctional FePt–Au heterodimers: promising nanotheranostic agents for dual-modality MR/CT imaging diagnosis and in situ cancer therapy

We report the synthesis of multifunctional FePt–Au hybrid nanoparticles via a simple hydrothermal approach and their potential application in cancer dual-modality MR/CT imaging diagnosis and simultaneous in situ therapy.

Recent applications of carbon nanomaterials in fluorescence biosensing and bioimaging

A review of recent applications of carbon nanomaterials in fluorescence biosensing and bioimaging.